Kolexia
Rochefort Pauline Oncologie médicale
Rochefort Pauline
Oncologie médicale
Centre Léon-Bérard
Lyon, France
47 Activités
262 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas Métastase tumorale Tumeurs de l'estomac Sarcomes Tumeurs de l'oesophage Carcinome du canal pancréatique Tumeurs du sein Sarcome d'Ewing

Collaborateurs

Voir plus
Sarabi Matthieu
Sarabi Matthieu
Cabinet libéral, Rillieux-la-Pape, France
De La Fouchardiere Christelle
De La Fouchardiere Christelle
Centre Paoli-Calmettes, Marseille, France
Desseigne Francoise
Desseigne Francoise
Centre Léon-Bérard, Lyon, France
Cassier Philippe
Cassier Philippe
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
B3TSI
8 collaboration(s)
Dernière en 2023
Zeste Research
4 collaboration(s)
Dernière en 2021
Servier
3 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
1684TiP PARPiPANC: A multicentric, single arm, phase II assessing niraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
ABLE02: A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Targeting HER2 in metastatic gastroesophageal adenocarcinomas: What is new?
Bulletin du cancer   10 octobre 2022
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3.
Journal of personalized medicine   12 avril 2022
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program.
Translational oncology   15 novembre 2021
Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report.
Frontiers in oncology   24 septembre 2021
Immune checkpoint inhibitor sensitivity of DNA repair deficient tumors.
Immunotherapy   08 septembre 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.
ESMO open   27 janvier 2021
FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study.
Current oncology (Toronto, Ont.)   01 août 2019